Urologic Oncology-Seminars and Original Investigations, 38, 5, pp. 440-448 UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Urologic Oncology-Seminars and Original Investigations, 38, 440-448 Hentschel, A E, van Rhijn, B W G, Bründl, J, Compérat, E M, Plass, K, Rodríguez, O, Henríquez, J D S, Hernández, V, de la Peña, E, Alemany, I, Turturica, D, Pisano, F, Soria, F, Čapoun, O, Bauerová, L, Pešl, M, Bruins, H M, Runneboom, W, Herdegen, S, Breyer, J, Brisuda, A, Scavarda-Lamberti, A, Calatrava, A, Rubio-Briones, J, Seles, M, Mannweiler, S, Bosschieter, J, Kusuma, V R M, Ashabere, D, Huebner, N, Cotte, J, Mertens, L S, Cohen, D, Lunelli, L, Cussenot, O, Sheikh, S E, Volanis, D, Coté, J-F, Rouprêt, M, Haitel, A, Shariat, S F, Mostafid, A H, Nieuwenhuijzen, J A, Zigeuner, R, Dominguez-Escrig, J L, Hacek, J, Zlotta, A R, Burger, M, Evert, M, Hulsbergen-van de Kaa, C A, van der Heijden, A G, Kiemeney, L A L M, Soukup, V, Molinaro, L, Gontero, P, Llorente, C, Algaba, F, Palou, J, N'Dow, J, Babjuk, M, van der Kwast, T H & Sylvester, R J 2020, ' Papillary urothelial neoplasm of low malignant potential (PUN-LMP) : Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019? ', Urologic Oncology, vol. 38, no. 5, doi: 10.1016/j.urolonc.2019.10.002, pp. 440-448 . https://doi.org/10.1016/j.urolonc.2019.10.002 Urologic Oncology, 38(5):doi: 10.1016/j.urolonc.2019.10.002, 440-448. Elsevier Inc.
European Urology, 79(4), 480-488. Elsevier EUROPEAN UROLOGY r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Sylvester, R J, Rodríguez, O, Hernández, V, Turturica, D, Bauerová, L, Bruins, H M, Bründl, J, van der Kwast, T H, Brisuda, A, Rubio-Briones, J, Seles, M, Hentschel, A E, Kusuma, V R M, Huebner, N, Cotte, J, Mertens, L S, Volanis, D, Cussenot, O, Subiela Henríquez, J D, de la Peña, E, Pisano, F, Pešl, M, van der Heijden, A G, Herdegen, S, Zlotta, A R, Hacek, J, Calatrava, A, Mannweiler, S, Bosschieter, J, Ashabere, D, Haitel, A, Côté, J F, El Sheikh, S, Lunelli, L, Algaba, F, Alemany, I, Soria, F, Runneboom, W, Breyer, J, Nieuwenhuijzen, J A, Llorente, C, Molinaro, L, Hulsbergen-van de Kaa, C A, Evert, M, Kiemeney, L A L M, N'Dow, J, Plass, K, Čapoun, O, Soukup, V, Dominguez-Escrig, J L, Cohen, D, Palou, J, Gontero, P, Burger, M, Zigeuner, R, Mostafid, A H, Shariat, S F, Rouprêt, M, Compérat, E M, Babjuk, M & van Rhijn, B W G 2021, ' European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade : An Update from the EAU NMIBC Guidelines Panel[Formula presented] ', European Urology, vol. 79, no. 4, pp. 480-488 . https://doi.org/10.1016/j.eururo.2020.12.033 European Urology, 79, 4, pp. 480-488 European Urology, 79, 480-488